Welcome to MS Views and News blog


MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

May 19, 2015

Mindful Relaxation with your Pet

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
Learn more: http://www.mindfulpetitations.org/ ~~~~~~~~~~~~~~~~~~~~  Keep CURRENT with MS Views and News – OPT-IN here . . Visit our MS Learning Channel on YouTube:…
Alternative therapies and devices for Multiple Sclerosis (MS)

May 19, 2015

Herbal Therapy What You Don’t Know, Can Hurt You

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
  • News from the MS Foundation
    /
  • Vitamins and Supplements
    /
By: MSF Staff and reviewed by the MSF Medical Advisory Board Herbal medicine is nothing new. In fact, it’s been…
Alternative therapies and devices for Multiple Sclerosis (MS)

May 19, 2015

Video: Knowing when, to switch an MS Medication

  • MS Drug Therapies
    /
  • MS Educational Programs
    /
  • MS Views and News
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis Videos
    /
Click the above to listen and learn on the topic: Knowing When, to Switch a Multiple Sclerosis (MS) Medication ~~~~~~~~~~~~~~~~~~~~…
MS Drug Therapies

May 19, 2015

PARADIGMS – A Research Study for Children with Multiple Sclerosis (MS)

  • MS Research Study and Reports
    /
  • Pediatric MS
    /
The PARADIGMS Study  PARADIGMS is a 24-month research study intended to see if an FDA-approved oral disease modifying treatment (DMT)…
MS Research Study and Reports

May 18, 2015

PLEGRIDY Three-Year Data Support Long-Term Safety and Efficacy in MS Patients

  • MS Drug Therapies
    /
PLEGRIDY® (Peginterferon Beta-1a) Three-Year Data Presented at AAN Annual Meeting Support Long-Term Safety and Efficacy in Multiple Sclerosis Patients Interim…
MS Drug Therapies

May 18, 2015

GENZYME TO COLLABORATE WITH ABLYNX ON MULTIPLE SCLEROSIS NANOBODIES, RESEARCH PROJECT

  • MS Research Study and Reports
    /
GHENT, Belgium, May 18, 2015 (GLOBE NEWSWIRE) — Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced that it has entered into an exclusive…
MS Research Study and Reports

May 18, 2015

Mid-Michigan resident tests out new MS treatment

  • MS Drug Therapies
    /
OWOSSO, MI (WNEM) – A new groundbreaking treatment for multiple sclerosis is helping slow down the disease. A patient in Owosso was the…
MS Drug Therapies

May 18, 2015

Opexa Developing Tcelna as a True Personalized MS Therapy For SPMS, RRMS

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
Multiple Sclerosis News Today Opexa Developing Tcelna as a True Personalized MS Therapy For SPMS, RRMS Maureen Newman After the…
MS Drug Therapies

May 13, 2015

News for those affected by MS in Louisville, KY

  • MS Educational Programs
    /
Registration to Open by Wednesday May 20, 2015 for our First Program in Louisville, KY Jenifer Patterson is an Advanced…
MS Educational Programs

May 13, 2015

Oral Drugs May Reduce Preference for Injectable Drugs in Multiple Sclerosis Treatment

  • MS Drug Therapies
    /
Frost & Sullivan recently published a report entitled “A Product and Pipeline Analysis of the Multiple Sclerosis Therapeutics Market” providing insight into…
MS Drug Therapies

Categories

Latest Blog Posts